期刊文献+

HNF4α在非酒精性脂肪肝发生发展中的机制研究 被引量:4

Mechanisms of HNF4 Alpha in Development of Nonalcoholic Fatty Liver Disease
原文传递
导出
摘要 为了探讨非酒精性脂肪肝(Nonalcoholic fatty liver disease,NAFLD)发病机制,选用小鼠脂肪肝和离体肝原代细胞培养作为非酒精性脂肪肝模型。通过免疫印迹、逆转录-聚合酶链反应、免疫共沉淀和免疫荧光检测肝脏核因子4α(Hepatocyte nuclear factor 4-alpha,HNF4-α)核质分布、转录活性和HNF4α下游脂代谢相关基因和脂代谢的表达水平。结果显示:高脂饮食诱导肝脏脂质沉积,升高脂多糖(Lipopolysaccharide,LPS)、棕榈酸(Palmitate,PA)和肿瘤坏死因子α(Tumor necrosis factor-α,TNF-α)的表达水平,这些因子能够激活蛋白激酶C(Protein kinase C,PKC)。PKC通过磷酸化显著抑制HNF4α下游基因微粒体甘油三酯转运蛋白(Microsomal triglyceride transfer protein,MTTP)和载脂蛋白B(Apolipoprotein B,Apo B)的转录活性,妨碍肝脏低密度脂蛋白(VLDL)的装配和甘油三酯(TG)外排。过多的甘油三酯滞留在肝脏,进一步加剧脂肪肝的发展。 In order to explore the mechanism of development of nonalcoholic fatty liver disease ( Nonalcoholic fatty liver disease, NAFLD) ,the mice in vivo with fatty liver and primary hepatocyte culture were chosen as nonalcoholic fatty liver model. Western blot, Reverse transcription-polymerase chain reaction, Immunoprecipitation and Immunofluorescence techniques were used to detect the description of nucleas and cytoplasmic hepatocyte nuclear factor 4-alpha( Hepatocyte nuclear factor 4-alpha, HNF4-α), transcrip- tion activity and the expression level of HNF4α downstream lipid metabolism related genes and the level of lipid metabolism. The results showed that high fat diet induced hepatic lipid accumulation and increased the expression levels of lipopolysaecharide ( Lipopolysaccharide, LPS), palmitic acid ( Palmitate, PA) and tumor necrosis factor α ( Tumor necrosis factor α, TNF-α), while the expression levels of these factors can activate protein kinase C ( Protein kinase C, PKC). Furthermore, the activation of PKC signifi- cantly represses the transcriptional level of HNF4α down-stream microsomal triglyceride transfer protein (Microsomal Triglyceride Transfer Protein, MTTP ) and apolipoproteinB ( ApolipoproteinB, ApoB) by mediating phosphorylation ( P 〈 0.05 ), subsequently obvi- ously reduces assembling of very low density lipoprotein (VLDL) and hepatic exportation of triglyceride (TG) ( P 〈 0.05 ). Excessive accumulation of triglycerides in the liver further promotes the development of NAFLD.
出处 《药物生物技术》 CAS 2016年第3期213-217,共5页 Pharmaceutical Biotechnology
基金 国家自然科学基金(No.81473241 No.81172004) 国家自然科学基金青年基金(No.81400613) 江苏省自然青年基金(No.BK20140901)
  • 相关文献

参考文献14

  • 1Dharel N, Fuchs M. Nonalcoholic fatty liver disease-a major pub- lic health challenge for the 21st century [ J]. JSM Gastroenterol Hepatol,2014 ,2:1018-1018.
  • 2Xiao J, Han N, Yang D, et al. Liver steatosis in Chinese HIV- infected patients with hypertriglyceridemia: characteristics and independent risk factors [ J ]. Virology J,2013,10 ( 1 ) :261-261.
  • 3Simo R, Saez-Lopez C, Lecube A, et al. Adiponectin upregulates SHBG production: molecular mechanisms and potential implica- tions[ J]. Endocrinology,2014,155 (8) :2820-2830.
  • 4Xie X,Liao H,Dang H,et al. Down-regulation of hepatic HNF4ct gene expression during hyperinsulinemia via SREBPs [ J ]. Molec Endoc ,2009,23 ( 4 ) :434-443.
  • 5Naiki T,Nagaki M,Shidoji Y,et al. Functional activity of human hepatoma cells tr.ansfected with adenovirus-mediated hepatocyte nuclear factor (HNF)-4 gene[ J]. Cell Transplant,2004,13(4) : 393 -403.
  • 6Holloway M G, Miles G D, Dombkowski A A, et al. Liver-specific hepatocyte nuclear factor- 4α deficiency : greater impact on gene expression in male than in female mouse liver[ J]. Molec Endoc, 2008,22(5) :1274-1286.
  • 7Yin L,Ma H,Ge X,et al. Hepatic hepatocyte nuclear factor 4α is essential for maintaining trlglyceride and cholesterol homeostasis [ J]. Arterios, Throm, Vasc Bio1,2011,31 (2) :328-336.
  • 8Guardiola M, Oliva I, Guillaumet A, et al. Tissue-specific DNA methylation profiles regulate liver-specific expression of the APOA1/C3/A4/A5 cluster and can be manipulated with demeth- ylating agents on intestinal cells [ J ]. Atherosclerosis, 2014,237 (2) :528-535.
  • 9Tessad P, Kiwanuka E, Barazzoni R, et al. Decreased VLDL-Apo B 1130 fractional synthesis rate despite hypertriglyceridemia in subjects with type 2 diabetes and nephropathy[ J]. J Clinic Endoc ,J & Metab ,2015 ,111( 11 ) :4098-4105.
  • 10Johnson L A, Kim H S, Knudson M J, et al. Diabetic atherosclero- sis in APOE * 4 mice: synergy between lipoprotein metabolism and vascular inflammation [ J ]. J Lipid Res, 2013,54 ( 2 ) : 386-396.

二级参考文献9

  • 1Nakamura T, Nishizawa T, Hagiya M, et al. Molecular cloning and expression of human hepatocyte growth factor[J].Nature, 1989,342: 440.
  • 2Kosai K, Matsumoto K, Nagata S, etal. Abrogation of Fasinduced fulminant hepatic failure in mice by hepatocyte growth factor[J]. Biochem Biophys Res Commun, 1998,244: 683
  • 3Mizuno S, Kurosawa T, Matsumoto K, et al. Hepatocyte growth factor prevents renal fibrosis and dysfunction in a mouse model of chronic renal disease[J]. J Clin Invest, 1998,101:1827.
  • 4Morishita R, Aoki M, Hashiya N, et al. Therapeutic angiogenesis using hepatocyte growth factor (HGF) [J]. Curr Gene Ther,2004,4:199.
  • 5Yoshida S, Matsumoto K, Tomioka D, et al. Recombinant hepatocyte growth factor accelerates cutaneous wound healing in a diabetic mouse model[J]. Growth Factors ,2004 Jun,22:111.
  • 6Imler J L, Chartier C, Dreyer D, et al. Novel complementation cell lines derived from human lung carcinoma A549 cells support the growth of E1-deleted adenovirus vectors [J].Gene Ther, 1996, 3:75.
  • 7Kozarsky KF, Wilson JM. Gene therapy: adenovirus vectors[J]. CurrOpin Genet Dev, 1993, 3(3):499.
  • 8Ueki T, Kaneda Y, Tsutsui H, et al. Hepatocyte growth factor gene therapy of liver cirrhosis in rats [J]. Nature Med, 1999,5: 226.
  • 9哈小琴,王新国,吴祖泽.人肝细胞生长因子基因表达质粒的构建及其活性研究[J].中国应用生理学杂志,2002,18(3):278-282. 被引量:11

共引文献7

同被引文献21

引证文献4

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部